OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progress of Statin Therapy in the Treatment of Idiopathic Pulmonary Fibrosis
Leiya Kou, Pei Kou, Guangwei Luo, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-18
Open Access | Times Cited: 14

Showing 14 citing articles:

Comprehensive review of potential drugs with anti-pulmonary fibrosis properties
Jie Ma, Gang Li, Han Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116282-116282
Open Access | Times Cited: 18

The current landscape of antifibrotic therapy across different organs: A systematic approach
Isabel Fuster‐Martínez, Sara Calatayud
Pharmacological Research (2024) Vol. 205, pp. 107245-107245
Open Access | Times Cited: 7

Ectopic and visceral fat deposition in aging, obesity, and idiopathic pulmonary fibrosis: an interconnected role
Xiaoyun Cheng, Shuhan Jiang, Boyu Pan, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 12

The Effects of Statins on Respiratory Symptoms and Pulmonary Fibrosis in COVID-19 Patients with Diabetes Mellitus: A Longitudinal Multicenter Study
Mohammadamin Sadeghdoust, Farnaz Aligolighasemabadi, Tania Dehesh, et al.
Archivum Immunologiae et Therapiae Experimentalis (2023) Vol. 71, Iss. 1
Open Access | Times Cited: 7

Lung transplantation in a woman with paraquat poisoning that led to pulmonary fibrosis—Widely reported by the media: A case report
Yunxiao Wu, Ning Li, Suyan Li, et al.
Medicine (2022) Vol. 101, Iss. 49, pp. e32263-e32263
Open Access | Times Cited: 5

Dysregulated lipid metabolism in lymphangioleiomyomatosis pathogenesis as a paradigm of chronic lung diseases
Clara Bernardelli, Anna Caretti, Elena Lesma
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 2

Statin use and its association with decreased risk of esophageal squamous cell carcinoma in betel nut chewers
Chih‐Lang Lin, Wan‐Ming Chen, Ben‐Chang Shia, et al.
Thoracic Cancer (2023) Vol. 14, Iss. 23, pp. 2241-2250
Open Access | Times Cited: 2

Atorvastatin and ezetimibe protect against hypercholesterolemia-induced lung oxidative stress, inflammation, and fibrosis in rats
Porrnthanate Seenak, Sarawut Kumphune, Thanit Prasitsak, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 4

Retracted: Progress of Statin Therapy in the Treatment of Idiopathic Pulmonary Fibrosis
Oxidative Medicine And Cellular Longevity
Oxidative Medicine and Cellular Longevity (2024) Vol. 2024, pp. 1-1
Open Access

The role of protein prenylation inhibition through targeting FPPS by zoledronic acid in the prevention of renal fibrosis in rats
Reham Hussein Mohamed, Dina Sayed Abdelrahim, Nesma Hussein Abdel hay, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access

Genetic association of lipids and lipid lowering drug target genes with sarcoidosis
Wei Tan, Zicheng Liang, Yu Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access

Effect of Rosuvastatin on Rabbit Valve Interstitial Cell Differentiation Induced by Transforming Growth Factor-Β1 based on Α – Smooth Muscle Actin Expression
Wisdamedika Valentidenta, Yudi Her Oktaviono, Achmad Lefi, et al.
Journal for ReAttach Therapy and Developmental Diversities (2023)
Open Access

Page 1

Scroll to top